Journal of the National Cancer Institute·26 SepPhysical activity and molecular residual disease in stage III colon cancer: Findings from Cancer and Leukemia Group B (Alliance)/SWOG 80702Trial in 763 peopleGut and microbiomePaper
ENDO 2025 Abstract·23 OctOR19-06 Safety and Effectiveness of Sulfonylureas for Pancreas-Cancer Induced Metabolic DysregulationTrial in peopleInterventionsPaper